
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Ghassan Al-Duhaini to replace Abu Shabab as Popular Forces leader in Gaza05.12.2025 - 2
Ukraine demands army of 800,000 under peace plan11.12.2025 - 3
Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived.19.12.2025 - 4
6 Fun Urban areas For Seniors To Travel06.06.2024 - 5
She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.'06.11.2025
4 Electric Vehicle Brands: Execution, Unwavering quality, and Development
Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
Bayer reports positive results for blood thinner after 2023 setback
Farmers call for French blockades over cow disease cull
Heavenly Pastry Confrontation: Pick Your #1 Sweet Treat!
Newly discovered link between traumatic brain injury in children and epigenetic changes could help personalize treatment for recovering kids
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
This Week In Space podcast: Episode 186 — Snow on the Moon?
CDC's upcoming vote on hepatitis B vaccine could impact childhood immunization













